Hypertension
Conditions
Interventions
When the patients do not achieve blood pressure goal,irbesartan will be newly admitted to them.If they have already taken any other angiotensin 2 receptor blocker(ARB), the ARB will be changed to irbe
Sponsors
Saitama medical University,Department of Nephrology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Older than 20 y.o. and younger than 75 y.o. when informed consent was taken. (2)Patients who gave an written informed consent. (3)Inadequate control of BP(Patients who don not attain target BP of JSH 2009)
Exclusion criteria
Exclusion criteria: (1)Patients who have allergy of irbesartan. (2)Patients who get pregnant or possibility of pregnant. (3)Patients who have bil renal artery stenosis or renal artery stenosis of unilateral kidney. (4)Dialysis patients (5)Patients of hyperkalemia (6)Patients of severe renal dysfunction (7)Liver dysfunction especially biliary cirrhosis and biliary congestion. (8)Patients who were considered inappropriate for the study by treating doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate renal function, lipid,uric acid,after 6 months. | — |
Countries
Japan
Contacts
Public ContactTomohiro Kikuta
Saitama medical University Department of Nephrology
Outcome results
None listed